US 10221455
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
granted A61KA61K2039/6031A61K2039/6056
Quick answer
US patent 10221455 (Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy) held by BIOVERATIV THERAPEUTICS INC. expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/6031, A61K2039/6056, A61K38/21, A61K38/37